Albumin (Human, Octapharma)

人血白蛋白(Octapharma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAlbumin (Human, Octapharma)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionColloidal osmotic pressure modulators
TargetsNot applicable
Therapy Area/IndicationsHypovolemiaShock, HemorrhagicHypoalbuminemia
Global Approved IndicationsHypovolemiaShock, HemorrhagicHypoalbuminemia
Approved Indications in ChinaHypovolemiaShock, Hemorrhagic
Original Approved Country/TerritoryUnited States
Original Approved Date2006/10/17
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOctapharma
China Registration ClassN/A

Develop Information

Active CompaniesOctapharma Ag
Inactive CompaniesN/A
Active IndicationsHypovolemiaShock, HemorrhagicHypoalbuminemia
Inactive IndicationsN/A

Other Information

ATC CodeB05AA01
Related LinksWikipedia